Mateus Dalcin Luchese
Papers
1
Total Citations
5
H-Index
1
About
Mateus Dalcin Luchese is a biotechnologist whose research focuses on the development and characterization of biopharmaceuticals, particularly monoclonal antibodies with biosimilar potential. His most notable contribution is the creation of a novel Chinese hamster ovary (CHO)-derived cell line engineered to express an anti-TNFα monoclonal antibody, a critical therapeutic for autoimmune diseases like rheumatoid arthritis. This work, published in 2018 and garnering 5 citations, demonstrates his expertise in cell line engineering and upstream bioprocessing, aiming to reduce production costs and improve access to biologic drugs. Luchese’s research bridges fundamental cell biology and applied pharmaceutical development, offering a platform for scalable, high-yield antibody production. His findings contribute to the growing field of biosimilars, which expand treatment options globally. Through this pioneering study, Luchese has established a foundation for future work in optimizing expression systems and validating biosimilarity, marking him as a promising researcher in industrial biotechnology.
Research Focus
Key Achievements
Top Papers
- 1